The availability of a suitable screening test does not justify screening for a disease unless the disease is important, relatively prevalent, and amenable to early treatment. Screening for a disease which has the necessary characteristics cannot be justified unless there is an acceptable, reliable and valid test which can be carried out at reasonable cost.
Screening which is carried out without knowledge and consideration of these criteria is likely to be wasteful of scarce medical resources and may actually do more harm than good.
This article has been cited by other articles:
![]() |
B. T. van Maldegem, M. Duran, R. J. A. Wanders, K. E. Niezen-Koning, M. Hogeveen, L. Ijlst, H. R. Waterham, and F. A. Wijburg Clinical, biochemical, and genetic heterogeneity in short-chain acyl-coenzyme A dehydrogenase deficiency. JAMA, August 23, 2006; 296(8): 943 - 952. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Waisbren Newborn screening for metabolic disorders. JAMA, August 23, 2006; 296(8): 993 - 995. [Full Text] [PDF] |
||||
![]() |
J. F. Hick Apnea guideline questioned AAP News, August 1, 2002; 21(2): 72 - 72. [Full Text] |
||||
![]() |
C. Meyer, J. Witte, A. Hildmann, K.-H. Hennecke, K.-U. Schunck, K. Maul, U. Franke, H. Fahnenstich, H. Rabe, R. Rossi, et al. Neonatal Screening for Hearing Disorders in Infants at Risk: Incidence, Risk Factors, and Follow-up Pediatrics, October 1, 1999; 104(4): 900 - 904. [Abstract] [Full Text] |
||||
![]() |
B. L. Therrell Jr, S. A. Berenbaum, V. Manter-Kapanke, J. Simmank, K. Korman, L. Prentice, J. Gonzalez, and S. Gunn Results of Screening 1.9 Million Texas Newborns for 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia Pediatrics, April 1, 1998; 101(4): 583 - 590. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. McCarthy, S. Z. Spiesel, C. A. Stashwick, R. C. Ablow, S. J. Masters, and T. F. Dolan JR Radiographic Findings and Etiologic Diagnosis in Ambulatory Childhood Pneumonias Clinical Pediatrics, November 1, 1981; 20(11): 686 - 691. [Abstract] [PDF] |
||||